Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor
- 31 March 1995
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 98 (3) , 257-265
- https://doi.org/10.1016/s0002-9343(99)80372-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- EFFECTS OF ARGININE VASOPRESSIN, ANGIOTENSIN II AND ENDOTHELIN‐1 ON THE RELEASE OF BRAIN NATRIURETIC PEPTIDE IN VIVO AND IN VITROClinical and Experimental Pharmacology and Physiology, 1992
- Accelerated secretion of brain natriuretic peptide from the hypertrophied ventricles in experimental malignant hypertension.Hypertension, 1992
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic functionThe Lancet, 1990
- Isolation and sequence determination of human brain natriuretic peptide in human atriumFEBS Letters, 1990
- Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trialThe American Journal of Cardiology, 1989
- The presence of brain natriuretic peptide of 12,000 daltons in porcine heartBiochemical and Biophysical Research Communications, 1988
- A new natriuretic peptide in porcine brainNature, 1988
- Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.Circulation, 1978
- Measurement of Left Ventricular Wall Thickness and Mass by EchocardiographyCirculation, 1972